Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Full Text Full Text (PDF) PPT slides of all figures Alert me when this article is cited Citation Map Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JEM Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Metelitsa, L. S. Articles by Seeger, R. C. Search for Related Content PubMed PubMed Citation Articles by Metelitsa, L. S. Articles by Seeger, R. C. Social Bookmarking                      What's this?

¹ Department of Pediatrics, Division of Hematology-Oncology, Childrens Hospital Los Angeles and ² Biostatistics Core Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA 90027
³ Cancer Immunology and AIDS Department, Dana Farber Cancer Institute, Boston, MA 02115
⁴ Children's Oncology Group, Arcadia, CA 91006

Address correspondence to Robert C. Seeger, Dept. of Pediatrics, Div. of Hematology-Oncology, MS #57, Childrens Hospital Los Angeles, 4650 Sunset Blvd., Los Angeles, CA 90027. Phone: (323) 669-5618; Fax: (323) 664-9455; email: rseeger{at}chla.usc.edu

CD1d-restricted V24-J18–invariant natural killer T cells (iNKTs) are potentially important in tumor immunity. However, little is known about their localization to tumors. We analyzed 98 untreated primary neuroblastomas from patients with metastatic disease (stage 4) for tumor-infiltrating iNKTs using TaqMan^® reverse transcription polymerase chain reaction and immunofluorescent microscopy. 52 tumors (53%) contained iNKTs, and oligonucleotide microarray analysis of the iNKT⁺ and iNKT^– tumors revealed that the former expressed higher levels of CCL2/MCP-1, CXCL12/SDF-1, CCL5/RANTES, and CCL21/SLC. Eight tested neuroblastoma cell lines secreted a range of CCL2 (0–21.6 ng/ml), little CXCL12 (0.1 ng/ml), and no detectable CCL5 or CCL21. CCR2, the receptor for CCL2, was more frequently expressed by iNKT compared with natural killer and T cells from blood (P < 0.001). Supernatants of neuroblastoma cell lines that produced CCL2 induced in vitro migration of iNKTs from blood of patients and normal adults; this was abrogated by an anti-CCL2 monoclonal antibody. CCL2 expression by tumors was found to inversely correlate with MYCN proto-oncogene amplification and expression (r = 0.5, P < 0.001), and MYCN-high/CCL2-low expression accurately predicted the absence of iNKTs (P < 0.001). In summary, iNKTs migrate toward neuroblastoma cells in a CCL2-dependent manner, preferentially infiltrating MYCN nonamplified tumors that express CCL2.

Key Words: lymphocytes • tumor-infiltrating • T lymphocyte subsets • cell movement • immunologic surveillance

Abbreviations used in this paper: GalCer, -galactosylceramide; DAPI, 4',6-diamidine-2'-phenylindole dihydrochloride; FU, fluorescence units; IHC, immunohistochemistry; iNKT, V24-J18–invariant natural killer T cell; TEM, transendothelial migration.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Moreno, M., Molling, J. W., von Mensdorff-Pouilly, S., Verheijen, R. H. M., Hooijberg, E., Kramer, D., Reurs, A. W., van den Eertwegh, A. J. M., von Blomberg, B. M. E., Scheper, R. J., Bontkes, H. J. (2008). IFN-{gamma}-Producing Human Invariant NKT Cells Promote Tumor-Associated Antigen-Specific Cytotoxic T Cell Responses. J. Immunol. 181: 2446-2454 [Abstract] [Full Text]  
• van der Vliet, H. J. J., Wang, R., Yue, S. C., Koon, H. B., Balk, S. P., Exley, M. A. (2008). Circulating Myeloid Dendritic Cells of Advanced Cancer Patients Result in Reduced Activation and a Biased Cytokine Profile in Invariant NKT Cells. J. Immunol. 180: 7287-7293 [Abstract] [Full Text]  
• Brown, C. E., Vishwanath, R. P., Aguilar, B., Starr, R., Najbauer, J., Aboody, K. S., Jensen, M. C. (2007). Tumor-Derived Chemokine MCP-1/CCL2 Is Sufficient for Mediating Tumor Tropism of Adoptively Transferred T Cells. J. Immunol. 179: 3332-3341 [Abstract] [Full Text]  
• Molling, J. W., Langius, J. A.E., Langendijk, J. A., Leemans, C. R., Bontkes, H. J., van der Vliet, H. J.J., von Blomberg, B. M. E., Scheper, R. J., van den Eertwegh, A. J.M. (2007). Low Levels of Circulating Invariant Natural Killer T Cells Predict Poor Clinical Outcome in Patients With Head and Neck Squamous Cell Carcinoma. JCO 25: 862-868 [Abstract] [Full Text]  
• Zeng, Y., Huebener, N., Fest, S., Weixler, S., Schroeder, U., Gaedicke, G., Xiang, R., Schramm, A., Eggert, A., Reisfeld, R. A., Lode, H. N. (2007). Fractalkine (CX3CL1)- and Interleukin-2-Enriched Neuroblastoma Microenvironment Induces Eradication of Metastases Mediated by T Cells and Natural Killer Cells. Cancer Res. 67: 2331-2338 [Abstract] [Full Text]  
• van der Vliet, H. J. J., van Vonderen, M. G. A., Molling, J. W., Bontkes, H. J., Reijm, M., Reiss, P., van Agtmael, M. A., Danner, S. A., van den Eertwegh, A. J. M., von Blomberg, B. M. E., Scheper, R. J. (2006). Cutting Edge: Rapid Recovery of NKT Cells upon Institution of Highly Active Antiretroviral Therapy for HIV-1 Infection. J. Immunol. 177: 5775-5778 [Abstract] [Full Text]  
• van der Vliet, H. J.J., Balk, S. P., Exley, M. A. (2006). Natural Killer T Cell-Based Cancer Immunotherapy.. Clin. Cancer Res. 12: 5921-5923 [Full Text]  
• Baev, D. V., Peng, X.-h., Song, L., Barnhart, J. R., Crooks, G. M., Weinberg, K. I., Metelitsa, L. S. (2004). Distinct homeostatic requirements of CD4+ and CD4- subsets of V{alpha}24-invariant natural killer T cells in humans. Blood 104: 4150-4156 [Abstract] [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS